LifeStance Health Group, Inc. (LFST) stock
LFSTNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/30243% above fair value
$14.17−0.31 (-2.14%)
Close on Nov 17, 2026Market cap $5.41BP/E 109.0Yield –
LifeStance Health revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
LifeStance Health's revenue for the twelve months ending Jun 30, 2026 was $1.58B, up 20.4% year over year. For fiscal 2025 it was $1.42B, up 13.9% from the year before. The highest annual figure on record is $1.42B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.42B | +13.9% |
| FY2024 | Dec 31, 2024 | $1.25B | +18.5% |
| FY2023 | Dec 31, 2023 | $1.06B | +22.8% |
| FY2022 | Dec 31, 2022 | $859.54M | +28.8% |
| FY2021 | Dec 31, 2021 | $667.51M | +214.1% |
| FY2019 | Dec 31, 2019 | $212.52M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $435.35M | +26.1% |
| Q1 FY2026 | Mar 31, 2026 | $403.48M | +21.2% |
| Q4 FY2025 | Dec 31, 2025 | $382.20M | +17.4% |
| Q3 FY2025 | Sep 30, 2025 | $363.81M | +16.3% |
| Q2 FY2025 | Jun 30, 2025 | $345.31M | +10.6% |
| Q1 FY2025 | Mar 31, 2025 | $332.97M | +10.8% |
| Q4 FY2024 | Dec 31, 2024 | $325.48M | +16.0% |
| Q3 FY2024 | Sep 30, 2024 | $312.72M | +19.0% |
| Q2 FY2024 | Jun 30, 2024 | $312.33M | +20.3% |
| Q1 FY2024 | Mar 31, 2024 | $300.44M | +18.9% |
| Q4 FY2023 | Dec 31, 2023 | $280.60M | +22.3% |
| Q3 FY2023 | Sep 30, 2023 | $262.90M | +20.8% |
| Q2 FY2023 | Jun 30, 2023 | $259.58M | +23.9% |
| Q1 FY2023 | Mar 31, 2023 | $252.59M | +24.4% |
| Q4 FY2022 | Dec 31, 2022 | $229.36M | +20.7% |
| Q3 FY2022 | Sep 30, 2022 | $217.56M | +25.2% |
| Q2 FY2022 | Jun 30, 2022 | $209.53M | +30.5% |
| Q1 FY2022 | Mar 31, 2022 | $203.10M | +41.9% |
| Q4 FY2021 | Dec 31, 2021 | $190.00M | +86.3% |
| Q3 FY2021 | Sep 30, 2021 | $173.84M | +282.5% |
| Q2 FY2021 | Jun 30, 2021 | $160.55M | – |
| Q1 FY2021 | Mar 31, 2021 | $143.13M | – |
| Q3 FY2020 | Sep 30, 2020 | $101.98M | – |
| Q2 FY2020 | Jun 30, 2020 | $45.45M | – |
See a number that looks wrong?